natgillin/translations-raw huggingface dataset:
Imprida is not recommended in early pregnancy (first 3 months), and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy. 
Jemanje zdravila Imprida v zgodnjem obdobju nosečnosti (v prvih 3 mesecih) ni priporočljivo, če pa ste noseči več kot 3 mesece, ga ne smete jemati, ker lahko uporaba po tretjem mesecu nosečnosti povzroči resno škodo vašemu otroku.
What Imprida is and what it is used for 
Kaj je zdravilo Imprida in za kaj ga uporabljamo
Do not take Imprida if you are allergic to amlodipine or to any other calcium channel blockers. 
Ne jemljite zdravila Imprida če ste alergični na amlodipin ali na katerikoli zaviralec kalcijevih kanalčkov.
The safety of Imprida has been evaluated in five controlled clinical studies with 5,175 patients, 2,613 of whom received valsartan in combination with amlodipine. 
Varnost zdravila Imprida so ocenjevali v petih kontroliranih kliničnih študijah s 5.175 bolniki, od katerih jih je 2.613 prejemalo valsartan v kombinaciji z amlodipinom.
Other medicines and Imprida 
Druga zdravila in zdravilo Imprida
The safety and efficacy of Imprida in children aged below 18 years have not been established. 
Varnost in učinkovitost zdravila Imprida pri otrocih, starih manj kot 18 let, nista bili dokazani.
What Imprida is and what it is used for What you need to know before you take Imprida 
Kaj je zdravilo Imprida in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Imprida
• Hypersensitivity to the active substances, to dihydropyridine derivatives, or to any of the 
• Preobčutljivost na zdravilne učinkovine, na dihidropiridinske derivate ali katero koli pomožno
If you have taken too many tablets of Imprida, or if someone else has taken your tablets, consult a doctor immediately. 
Če ste vzeli večji odmerek zdravila Imprida, kot bi smeli Če ste vzeli preveč tablet zdravila Imprida, ali je vaše tablete vzel kdo drug, se takoj posvetujte z zdravnikom.
The usual dose of Imprida is one tablet per day. 
Običajni odmerek zdravila Imprida je ena tableta na dan.
You can take Imprida with or without food. 
Zdravilo Imprida lahko vzamete s hrano ali brez nje.
If you think you may be allergic, talk to your doctor before taking Imprida. 
Če domnevate, da bi lahko bili alergični, se posvetujte z zdravnikom, preden vzamete zdravilo Imprida.
For convenience, patients receiving valsartan and amlodipine from separate tablets/capsules may be switched to Imprida containing the same component doses. 
Zaradi praktičnosti je možno bolnike, ki dobivajo valsartan in amlodipin v ločenih tabletah/kapsulah, prevesti na zdravilo Imprida, ki vsebuje enaka odmerka sestavin.
To date there is no experience of the safe use of Imprida in patients who have had a recent kidney transplantation. 
Doslej ni izkušenj glede varnosti uporabe zdravila Imprida pri bolnikih, ki jim je bila nedavno presajena ledvica.
What you need to know before you take Imprida 
Kaj morate vedeti, preden boste vzeli zdravilo Imprida
Interactions common to the combination No drug-drug interaction studies have been performed with Imprida and other medicinal products. 
Interakcije pogoste ob kombinaciji Študij medsebojnega delovanja z zdravilom Imprida in drugimi zdravili niso izvedli.
Stopping your treatment with Imprida may cause your disease to get worse. 
Če prenehate jemati zdravilo Imprida, se lahko vaša bolezen poslabša.
If you stop taking Imprida 
Če ste prenehali jemati zdravilo Imprida
If a diurectic is also used, the risk of lithium toxicity may presumably be increased further with Imprida. 
Če je uporabljen tudi diuretik, uporaba zdravila Imprida predvidoma poveča toksične učinke litija.
Talk to your doctor before taking Imprida: if you have been sick (vomiting or diarrhoea). 
Pred začetkom jemanja zdravila Imprida se posvetujte s svojim zdravnikom: če vam je bilo slabo (bruhanje ali driska).
Abrupt withdrawal of Imprida has not been associated with a rapid increase in blood pressure. 
Nenadna prekinitev zdravila Imprida ni povezana s hitrim zvišanjem krvnega tlaka.
If you get these symptoms, stop taking Imprida and contact your doctor straight away. 
Če opazite navedene simptome, takoj prenehajte jemati zdravilo Imprida in obvestite svojega zdravnika.
The amlodipine component of Imprida inhibits the transmembrane entry of calcium ions into cardiac and vascular smooth muscle. 
Amlodipin v zdravilu Imprida zavira transmembranski vstop kalcijevih ionov v srčne in žilne gladke mišice.
Imprida is available in packs containing 7, 14, 28, 30, 56, 90, 98 or 280 tablets and in multipacks comprising 4 cartons, each containing 70 tablets, or 20 cartons, each containing 14 tablets. 
Zdravilo Imprida je na voljo v pakiranjih, ki vsebujejo 7, 14, 28, 30, 56, 90, 98 ali 280 tablet in v skupnih pakiranjih s 4 škatlami, od katerih vsaka vsebuje 70 tablet, ali z 20 škatlami, od katerih vsaka vsebuje 14 tablet.
Imprida has not been studied in any patient population other than hypertension. 
Zdravilo Imprida ni raziskano pri nobeni drugi populaciji razen pri bolnikih s hipertenzijo.
if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren. 
če imate sladkorno bolezen ali okvarjeno delovanje ledvic in se zdravite z zdravilom za zniževanje krvnega tlaka, ki vsebuje aliskiren.
The rate and extent of absorption of Imprida are equivalent to the bioavailability of valsartan and amlodipine when administered as individual tablets. 
Hitrost in obseg absorpcije zdravila Imprida sta enakovredna biološki uporabnosti valsartana in amlodipina, uporabljenih v ločenih tabletah.
Clinically significant hypotension due to Imprida overdose calls for active cardiovascular support, including frequent monitoring of cardiac and respiratory function, elevation of extremities, and attention to circulating fluid volume and urine output. 
Klinično značilna hipotenzija zaradi prevelikega odmerka zdravila Imprida zahteva srčnožilno podporo, vključno s pogostim nadziranjem delovanja srca in dihal, dviganjem udov ter kontrolo krožečega volumna tekočine in izločanja urina.
Imprida combines two antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine belongs to the calcium antagonist class and valsartan to the angiotensin II antagonist class of medicines. 
Zdravilo Imprida vsebuje dve antihipertenzivni učinkovini s komplementarnima mehanizmoma delovanja za obvladanje krvnega tlaka pri bolnikih z esencialno hipertenzijo: amlodipin spada med zaviralce kalcijevih kanalčkov, valsartan pa med antagoniste angiotenzina II.
If you forget to take Imprida 
Če ste pozabili vzeti zdravilo Imprida
Additional information on the individual components Adverse reactions previously reported with one of the individual components (amlodipine or valsartan) may be potential adverse reactions with Imprida as well, even if not observed in clinical trials or during the post-marketing period. 
Dodatne informacije o posameznih zdravilnih učinkovinah Neželeni učinki, opisani za katero od obeh zdravilnih učinkovin (za amlodipin ali valsartan), so lahko tudi neželeni učinki zdravila Imprida, tudi če niso bili ugotovljeni v kliničnih preskušanjih ali v obdobju po prihodu zdravila na trg.
Frequency Imprida Amlodipine Valsartan 
Pogostnost Imprida Amlodipin Valsartan
Imprida was also studied in an active-controlled study of 130 hypertensive patients with mean sitting diastolic blood pressure ≥110 mmHg and <120 mmHg. 
Zdravilo Imprida so raziskali tudi v študiji, kontrolirani z učinkovino, pri 130 bolnikih s hipertenzijo, ki so imeli srednji diastolični krvni tlak sede ≥110 mm Hg in <120 mm Hg.
Consult a doctor immediately if you experience any of the following very rare, severe side effects after taking this medicine: - Sudden wheeziness, chest pain, shortness of breath or difficulty in breathing. 
Če med jemanjem zdravila opazite kateregakoli od spodaj naštetih, zelo redkih, hudih neželenih učinkov, se nemudoma posvetujte s svojim zdravnikom: - nenadna zasoplost, bolečine v prsih, kratka sapa ali težave z dihanjem.
Other possible side effects of Imprida: 
Drugi možni neželeni učinki zdravila Imprida:
If any of these apply to you, tell your doctor before taking Imprida. 
Če kaj od naštetega velja za vas, morate to povedati zdravniku, preden vzamete zdravilo Imprida.
Particular caution should be exercised when administering Imprida to patients with mild to moderate hepatic impairment or biliary obstructive disorders. 
Posebna previdnost je potrebna v primeru uporabe zdravila Imprida pri bolnikih z blago do zmerno okvaro jeter ali z obstruktivnimi biliarnimi boleznimi.
If hypotension occurs with Imprida, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline. 
Če se med uporabo zdravila Imprida pojavi hipotenzija, je treba bolnika poleči in mu, če je potrebno, dati intravensko infuzijo fiziološke raztopine.
- Severe skin reactions including intense skin rash, hives, reddening of the skin over your whole body, severe itching, blistering, peeling and swelling of the skin, inflammation of the mucous membranes (Stevens-Johnson Syndrome) or other allergic reactions. 
- hude kožne reakcije, vključno s hudim kožnim izpuščajem, koprivnico, pordelostjo kože po celem telesu, močnim srbenjem, pojavljanjem mehurjev, lupljenjem in otekanjem kože, vnetjem sluzničnih membran (Stevens-Johnsonov sindrom) in drugimi alergijskimi reakcijami.
• Obstruction of the outflow tract of the left ventricle (e.g. hypertrophic obstructive cardiomyopathy and high grade aortic stenosis). 
• Zapora pretoka krvi iz levega prekata (npr. hipertrofična obstruktivna kardiomiopatija in močno
Caution should be exercised when administering Imprida to patients with hepatic impairment or biliary obstructive disorders (see section 4.4). 
Previdnost je potrebna pri uporabi zdravila Imprida pri bolnikih z okvaro jeter ali obstruktivno biliarno boleznijo (glejte poglavje 4.4).
Posology The recommended dose of Imprida is one tablet per day. 
Priporočeni odmerek zdravila Imprida je ena tableta na dan.
Excessive hypotension was seen in 0.4% of patients with uncomplicated hypertension treated with Imprida in placebo-controlled studies. 
V študijah, kontroliranih s placebom, so čezmerno hipotenzijo opažali pri 0,4 % bolnikov z nezapleteno hipertenzijo, ki so dobivali zdravilo Imprida.
• Concomitant use of Imprida with aliskiren-containing products in patients with diabetes mellitus or renal impairment (GFR <60 ml/min/1.73 m2) (see sections 4.5 and 5.1). 
• Sočasna uporaba zdravila Imprida in zdravil, ki vsebujejo aliskiren, je kontraindicirana pri bolnikih s sladkorno boleznijo ali z okvaro ledvic (GFR <60 ml/min/1,73m 2) (glejte poglavji
if your doctor has told you that you have a narrowing of the valves in your heart (called “aortic or mitral stenosis”) or that the thickness of your heart muscle is abnormally increased (called “obstructive hypertrophic cardiomyopathy”). 
Zdravnik bo morda pregledal tudi delovanje če vam je zdravnik povedal, da imate zožene srčne zaklopke (t.i. aortno ali mitralno stenozo) ali nenormalno zadebeljeno srčno mišico (t.i. obstruktivno hipertrofično kardiomiopatijo).
Dual blockade of the renin-angiotensin-aldosterone system (RAAS) There is evidence that the concomitant use of ACE inhibitors, ARBs or aliskiren increases the risk of hypotension, hyperkalaemia and decreased renal function (including acute renal failure). 
Dvojno zaviranje sistema renin-angiotenzin-aldosteron (RAAS) Obstajajo dokazi, da sočasna uporaba zaviralcev ACE, antagonistov angiotenzinskih receptorjev ali aliskirena poveča tveganje za hipotenzijo, hiperkaliemijo in zmanjšano delovanje ledvic (vključno z akutno odpovedjo ledvic).
This is because grapefruit and grapefruit juice can lead to an increase in the blood levels of the active substance amlodipine, which can cause an unpredictable increase in the blood pressure lowering effect of Imprida. 
Grenivka in grenivkin sok lahko namreč povzročita zvišanje koncentracije zdravilne učinkovine amlodipina v krvi, kar lahko pripelje do nepredvidljivega povečanja učinka zdravila Imprida pri zniževanju krvnega tlaka.
Fertility There are no clinical studies on fertility with Imprida. 
Plodnost Kliničnih študij glede plodnosti pri uporabi zdravila Imprida ni.
Side effects reported with amlodipine or valsartan alone and either not observed with Imprida or observed with a higher frequency than with Imprida: 
Neželeni učinki, o katerih so poročali pri uporabi amlodipina ali valsartana samega, ki jih bodisi niso opažali pri uporabi zdravila Imprida ali pa so jih opažali z večjo pogostnostjo kot pri uporabi zdravila Imprida:
In this study (baseline blood pressure 171/113 mmHg), an Imprida regimen of 5 mg/160 mg titrated to 10 mg/160 mg reduced sitting blood pressure by 36/29 mmHg as compared to 32/28 mmHg with a regimen of lisinopril/hydrochlorothiazide 10 mg/12.5 mg titrated to 20 mg/12.5 mg. 
V tej študiji (izhodiščni krvni tlak 171/113 mm Hg) je shema odmerjanja zdravila Imprida 5 mg/160 mg, titrirana do 10 mg/160 mg, znižala krvni tlak sede za 36/29 mm Hg; v primerjavi s tem je shema odmerjanja lizinoprila/hidroklorotiazida 10 mg/12,5 mg, titrirana do 20 mg/12,5 mg, znižala krvni tlak za 32/28 mm Hg.
Over 1,400 hypertensive patients received Imprida once daily in two placebo-controlled trials. 
V dveh s placebom kontroliranih preskušanjih je zdravilo Imprida enkrat na dan dobivalo več kot 1.400 bolnikov s hipertenzijo.
Do not take Imprida with grapefruit or grapefruit 
Zdravila Imprida ne zaužijte skupaj z grenivko ali z grenivkinim sokom.
Cellulose microcrystalline Crospovidone Type A Silica, colloidal anhydrous Magnesium stearate 
Jedro tablete: mikrokristalna celuloza krospovidon tipa A brezvoden koloidni silicijev dioksid magnezijev stearat
Correction of this condition prior to administration of Imprida or close medical supervision at the start of treatment is recommended. 
Priporočljivo je, da pred začetkom uporabe zdravila Imprida, popravite to stanje ali bolniku zagotovite natančen zdravniški nadzor na začetku zdravljenja.
If any of the above applies to you, do not take Imprida and talk to your doctor. 
Če kaj od naštetega velja za vas, ne vzemite zdravila Imprida, temveč povejte zdravniku.
Do not use any Imprida pack that is damaged or shows signs of tampering. 
Zdravila Imprida ne uporabljajte, če je ovojnina poškodovana ali opazite, da je bila že odprta.
Imprida is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely. 
Če želite dojiti, bo zdravnik za vas izbral drugo zdravilo, še posebno če je vaš otrok še novorojenček ali je bil rojen prezgodaj.
Imprida is used to treat high blood pressure in adults whose blood pressure is not controlled enough with either amlodipine or valsartan on its own. 
Zdravilo Imprida uporabljamo za zdravljenje visokega krvnega tlaka pri odraslih, pri katerih krvni tlak ni dovolj dobro urejen samo z amlodipinom ali samo z valsartanom.
When switching eligible hypertensive patients (see section 4.1) with hepatic impairment to amlodipine or Imprida, the lowest available dose of amlodipine monotherapy or of the amlodipine component, respectively, should be used. 
Pri prehodu ustreznih bolnikov s hipertezijo (glejte poglavje 4.1) z jetrno okvaro na amlodipin ali zdravilo Imprida, je potrebno uporabiti najnižji razpoložljivi odmerek amlodipina v monoterapiji ali kot komponento.
Imprida is indicated in adults whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy. 
Zdravilo Imprida je indicirano pri odraslih, pri katerih krvni tlak ni ustrezno urejen ob monoterapiji z amlodipinom ali valsartanom.
There is no experience of overdose with Imprida. 
Izkušenj s prevelikim odmerjanjem zdravila Imprida ni.
When switching eligible elderly hypertensive patients (see section 4.1) to amlodipine or Imprida, the lowest available dose of amlodipine monotherapy or of the amlodipine component, respectively, should be used. 
Pri prehodu ustreznih starejših bolnikov s hipertezijo (glejte poglavje 4.1) na amlodipin ali zdravilo Imprida, je potrebno uporabiti najnižji razpoložljivi odmerek amlodipina v monoterapiji ali kot komponento.
You should never take Imprida if you are taking any of the following medicines used to treat high blood pressure: an ACE inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have 
če jemljete katero od naslednjih zdravil, ki se uporabljajo za zdravljenje visokega krvnega zaviralec ACE (na primer enalapril, lizinopril ali ramipril), zlasti če imate kakšne težave z ledvicami, ki so povezane s sladkorno boleznijo.
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction and development. 
Predklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih odmerkih, genotoksičnosti, kancerogenega potenciala ter vpliva na sposobnost razmnoževanja in razvoja ne kažejo posebnega tveganja za človeka.
No dosage adjustment of Imprida is required for patients with mild to moderate renal impairment (GFR >30 ml/min/1.73 m2). 
Okvara ledvic Pri bolnikih z blago do zmerno okvaro ledvic (GFR >30 ml/min/1,73 m2) odmerka zdravila Imprida ni treba prilagajati.
Following oral administration of Imprida, peak plasma concentrations of valsartan and amlodipine are reached in 3 and 6-8 hours, respectively. 
Po peroralni uporabi zdravila Imprida doseže valsartan največjo koncentracijo v plazmi v 3 urah, amlodipin pa v 6 do 8 urah.
70 film-coated tablets. 
7 filmsko obloženih tablet
Imprida should be used with caution to treat hypertension in patients with unilateral or bilateral renal artery stenosis or stenosis to a solitary kidney since blood urea and serum creatinine may increase in such patients. 
Pri bolnikih z enostransko ali obojestransko stenozo ledvične arterije oz. s stenozo v primeru solitarne ledvice je pri zdravljenju hipertenzije z zdravilom Imprida potrebna previdnost, saj pri takih bolnikih lahko pride do zvišanja koncentracij sečnine v krvi in kreatinina v serumu.
CYP3A4 inducers (anticonvulsant agents [e.g. carbamazepine, phenobarbital, phenytoin, fosphenytoin, primidone], rifampicin, Hypericum perforatum) There is no data available regarding the effect of CYP3A4 inducers on amlodipine. 
Induktorji CYP3A4 (antiepileptiki [kot so npr. karbamazepin, fenobarbital, fenitoin, fosfenitoin, primidon], rifampicin, Hypericum perforatum)
medicines used to treat fungal infections (e.g. ketoconazole, itraconazole); medicines used to treat bacterial infections (such as rifampicin, erythromycin, clarithromycin, talithromycin); verapamil, diltiazem (heart medicines); simvastatin (a medicine used to control high cholesterol levels); dantrolene (infusion for severe body temperature abnormalities); medicines used to protect against transplant rejection (ciclosporin). 
zdravila za okužbo s HIV ali AIDS (npr. ritonavir, indinavir, nelfinavir); zdravila za zdravljenje glivičnih okužb (npr. ketokonazol, itrakonazol); zdravila za zdravljenje bakterijskih okužb (kot so rifampicin, eritromicin, klaritromicin, talitromicin); verapamil, diltiazem (zdravili za srce); simvastatin (zdravilo za uravnavanje previsoke ravni holesterola); dantrolen (zdravilo v infuziji pri hudih odstopanjih telesne temperature); zdravila za preprečevanje zavrnitve presadka (ciklosporin).
Imprida tablets contain two substances called amlodipine and valsartan. 
Tablete zdravila Imprida vsebujejo dve učinkovini: amlodipin in valsartan.
ACE inhibitors or aliskiren (see also information under the headings “Do not take Imprida” and diuretics (a type of medicine also called “water tablets” which increases the amount of urine lithium (a medicine used to treat some types of depression); potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium and other substances that may increase potassium levels; certain types of painkillers called non-steroidal anti-inflammatory medicines (NSAIDs) or selective cyclooxygenase-2 inhibitors (COX-2 inhibitors). 
To še posebej velja za naslednja zdravila: zaviralci ACE ali aliskiren (glejte tudi informacije pod naslovoma “Ne jemljite zdravila Imprida” in “Opozorila in previdnostni ukrepi”); diuretike (vrsto zdravil, ki jim pravimo tudi "tablete za odvajanje vode" in povečajo nastajanje urina v telesu); litij (zdravilo, ki se uporablja za zdravljenje nekaterih vrst depresij); diuretike, ki varčujejo s kalijem, kalijeve dodatke, nadomestke soli, ki vsebujejo kalij, in druge učinkovine, ki lahko zvišajo koncentracijo kalija; določena zdravila proti bolečinam, ki jih imenujemo nesteroidna protivnetna zdravila (NSAID) ali selektivni zaviralci ciklooksigenaze-2 (zaviralci COX-2).
Grapefruit and grapefruit juice should not be consumed by people who are taking Imprida. 
Ljudje, ki jemljejo zdravilo Imprida, ne smejo uživati grenivk in grenivkinega soka.
Imprida 5 mg/80 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg alone. 
Zdravilo Imprida 5 mg/80 mg lahko uporabite pri bolnikih, pri katerih krvni tlak ni ustrezno urejen samo s 5 mg amlodipina ali z 80 mg valsartana.
CONDITIONS OR RESTRICTIONS REGARDING SUPPLY 
POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE
No information is available regarding the use of Imprida during breast-feeding, therefore Imprida is not recommended and alternative treatments with better established safety profiles during breastfeeding are preferable, especially while nursing a newborn or preterm infant. 
Za uporabo med dojenjem je bolje izbrati drugo zdravilo z dokazanim varnostnim profilom, še posebno če gre za dojenje novorojenčka ali nedonošenčka.
Imprida 10 mg/160 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg alone or with Imprida 5 mg/160 mg. 
Zdravilo Imprida 10 mg/160 mg lahko uporabite pri bolnikih, pri katerih krvni tlak ni ustrezno urejen samo z 10 mg amlodipina ali s 160 mg valsartana ali s kombinacijo zdravila Imprida 5 mg/160 mg.
Hypromellose Titanium dioxide (E171) Iron oxide, yellow (E172) Macrogol 4000 
Obloga: hipromeloza titanov dioksid (E171) rumeni železov oksid (E172) makrogol 4000 smukec
Very rare Very rare Very rare 
Srčne bolezni pogosti redki občasni zelo redki zelo redki
Your doctor may also check your kidney function; anticonvulsant agents (e.g. carbamazepine, phenobarbital, phenytoin, fosphenytoin, primidone); St. John's wort; nitroglycerin and other nitrates, or other substances called “vasodilators”; medicines used for HIV/AIDS (e.g. ritonavir, indinavir, nelfinavir); 
Zdravnik bo morda pregledal tudi delovanje vaših ledvic; antiepileptična zdravila (npr. karbamazepin, fenobarbital, fenitoin, fosfenitoin, primidon); šentjanževko; nitroglicerin in druge nitrate ter učinkovine, ki jih imenujemo “vazodilatatorji”;
Imprida should be discontinued immediately in patients who develop angioedema and should not be re-administered. 
Bolnikom, pri katerih pride do angioedema, je treba zdravilo Imprida takoj ukiniti.
Reproductive system and breast disorders 
Motnje reprodukcije in dojk redki
Amlodipine stops calcium from moving into the blood vessel wall which stops the blood vessels from 
Amlodipin prepreči prehajanje kalcija v steno žil in tako prepreči zožitev žil.
Component of a multipack, not to be sold separately. 
14 filmsko obloženih tablet (del skupnega pakiranja, ni namenjen ločeni prodaji).
The active substances of Imprida are amlodipine (as amlodipine besylate) and valsartan. 
Zdravilni učinkovini v zdravilu Imprida sta amlodipin (v obliki amlodipinijevega besilata) in valsartan.
Hepatic impairment Imprida is contraindicated in patients with severe hepatic impairment (see section 4.3). 
Okvara jeter Pri bolnikih s hudo okvaro jeter je zdravilo Imprida kontraindicirano (glejte poglavje 4.3).